This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Université Paris-Saclay. Active years: 2023.
Company Filing History:
1 out of 5,383 
1 out of 98 
Years Active: 2023
Title: Mathilde Lorscheider: Innovator in Nanoparticulate Prodrugs
Introduction
Mathilde Lorscheider is a prominent inventor based in Saint-Louis, France. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of anti-inflammatory drug formulations. Her innovative work focuses on corticosteroid prodrug nanoparticles, which have the potential to enhance therapeutic efficacy.
Latest Patents
Mathilde Lorscheider holds a patent for her invention titled "Nanoparticulate Prodrugs." This invention relates to a novel anti-inflammatory drug formulation that includes a nanoparticle comprising a therapeutic agent and a surface coating material. The patent also outlines a process for manufacturing these nanoparticles, as well as the pharmaceutical compositions and kits that utilize them. She has 1 patent to her name.
Career Highlights
Throughout her career, Mathilde has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Paris-Saclay. Her research has focused on advancing drug delivery systems and improving patient outcomes through innovative formulations.
Collaborations
Mathilde has collaborated with notable colleagues, including Nicolas Tsapis and Romain Canioni. Their joint efforts have contributed to the advancement of research in the field of nanoparticle drug delivery.
Conclusion
Mathilde Lorscheider's work in nanoparticulate prodrugs exemplifies her commitment to innovation in pharmaceutical science. Her contributions are paving the way for more effective anti-inflammatory treatments.